Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 9, 2018
PolarityTE™ Accelerates Sales Team for Targeted Regional Release of SkinTE™
SALT LAKE CITY, May 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) announced today that it is growing its commercial presence by hiring dedicated sales ...
May 9, 2018
MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for Afrezza® in India
WESTLAKE VILLAGE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD), a company focused on the development and commercialization of inhaled therapeutic products for ...
May 9, 2018
Zogenix Provides Corporate Update and Reports First Quarter Financial Results
EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
May 9, 2018
MannKind Corporation Reports 2018 First Quarter Financial Results
WESTLAKE VILLAGE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today reported financial results for the first quarter ended March 31, 2018. ...
May 9, 2018
Aileron Therapeutics Reports First Quarter 2018 Financial Results
CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other ...
May 9, 2018
TRACON Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 8, 2018
Moberg Pharma AB Interim Report January - March 2018
STOCKHOLM, May 8, 2018 /PRNewswire/ -- SIGNIFICANT GROWTH FOR ALL KEY BRANDS FIRST QUARTER (JAN-MAR 2018) Net revenue SEK 91.5 million (104.6) EBITDA SEK 21.9 ...
May 8, 2018
Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin ) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product
FORT LEE, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Kedrion Biopharma and Kamada Ltd. (KMDA) (KMDA.TA), two leading human-derived protein therapeutics companies, announced today that KEDRAB® [Rabies Immune ...
May 8, 2018
Brainstorm to Announce First Quarter Financial Results and Provide Corporate Update on Monday, May 14
NEW YORK and PETACH TIKVAH, Israel, May 8, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for ...
May 8, 2018
iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018
NASHUA, N.H., May 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
May 8, 2018
Altimmune to Announce First Quarter 2018 Financial Results on May 16
GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the ...
May 8, 2018
CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis
NEWARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
May 8, 2018
UroGen Pharma to Report First Quarter 2018 Financial Results on Tuesday, May 15, 2018
RA’ANANA, Israel and NEW YORK, May 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN) today announced that it will report first quarter 2018 financial ...
May 8, 2018
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
AUSTIN, Texas, May 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
May 8, 2018
Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
WARREN, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that, following the receipt ...
May 8, 2018
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA
WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), today provided an update on its new manufacturing submission for its Calcitriol vitamin ...
May 7, 2018
OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas
NANTES, France, May 07, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE) presented new preclinical data* that further supports the potential of OSE-127 for the treatment of ...
May 7, 2018
Aptose Exercises Early Option for CG-806 License From CrystalGenomics
SAN DIEGO and SEOUL, South Korea, May 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) and CrystalGenomics, Inc. (083790.KQ) today announced that Aptose ...
May 7, 2018
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2018 Financial Results on Thursday, May 10, 2018
BOSTON, May 07, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
May 7, 2018
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
Zug, Switzerland, May 7, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
Page 65 of 138